Cargando…
6-Shogaol Overcomes Gefitinib Resistance via ER Stress in Ovarian Cancer Cells
In women, ovary cancer is already the fifth leading cause of mortality worldwide. The use of cancer therapies, such as surgery, radiotherapy, and chemotherapy, may be a powerful anti-cancer therapeutic strategy; however, these therapies still have many problems, including resistance, toxicity, and s...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916959/ https://www.ncbi.nlm.nih.gov/pubmed/36768961 http://dx.doi.org/10.3390/ijms24032639 |